Genome-wide microarray analysis of brain gene expression in mice on a short-term high iron diet

Neurochemistry International

Volumn 56, Issue 6-7, 2010, Pages 856-863

  Johnstone, Daniel ^a   Milward, Elizabeth A ^a  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Brain; Diet; Gene expression; Iron; Lipofuscin; Lysosome; Microarray; Mouse

Indexed keywords

FERRITIN; IRON REGULATORY PROTEIN 1; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; INFLAMMATION; IRON INTAKE; MICROARRAY ANALYSIS; MOUSE; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

ANIMALS; APOFERRITINS; BRAIN; IRON; IRON OVERLOAD; IRON, DIETARY; MALE; MICE; MICE, INBRED AKR; NERVOUS SYSTEM DISEASES; NITRIC OXIDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

MUS;

EID: 77952291042     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.03.015     Document Type: Article

References (85)

1. Adams P.C., Reboussin D.M., Barton J.C., McLaren C.E., Eckfeldt J.H., McLaren G.D., Dawkins F.W., Acton R.T., Harris E.L., Gordeuk V.R., Leiendecker-Foster C., Speechley M., Snively B.M., Holup J.L., Thomson E., Sholinsky P. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005, 352:1769-1778.
2. 2 is a consequence of lysosomal rupture. Biochem J 2001, 356:549-555.
3. Arosio P., Levi S., Santambrogio P., Cozzi A., Luzzago A., Cesareni G., Albertini A. Structural and functional studies of human ferritin H and L chains. Curr Stud Hematol Blood Transfus 1991, 58:127-131.
4. Bach G. Mucolipidosis type IV. Mol Genet Metab 2001, 73:197-203.
5. Bargal R., Avidan N., Ben-Asher E., Olender Z., Zeigler M., Frumkin A., Raas-Rothschild A., Glusman G., Lancet D., Bach G. Identification of the gene causing mucolipidosis type IV. Nat Genet 2000, 26:118-123.
6. Baxter R.V., Ben Othmane K., Rochelle J.M., Stajich J.E., Hulette C., Dew-Knight S., Hentati F., Ben Hamida M., Bel S., Stenger J.E., Gilbert J.R., Pericak-Vance M.A., Vance J.M. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 2002, 30:21-22.
7. Bender R., Lange S. Adjusting for multiple testing-When and how?. J Clin Epidemiol 2001, 54:343-349.
8. Benhar M., Forrester M.T., Hess D.T., Stamler J.S. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 2008, 320:1050-1054.
9. Bomford A., Conlon-Hollingshead C., Munro H.N. Adaptive responses of rat tissue isoferritins to iron administration. Changes in subunit synthesis, isoferritin abundance, and capacity for iron storage. J Biol Chem 1981, 256:948-955.
10. Bostanci M.O., Bagirici F. Nitric oxide synthesis inhibition attenuates iron-induced neurotoxicity: a stereological study. Neurotoxicology 2008, 29:130-135.
11. Bowery N.G., Smart T.G. GABA and glycine as neurotransmitters: a brief history. Br J Pharmacol 2006, 147(Suppl 1):S109-S119.
12. Brunk U.T., Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med 2002, 33:611-619.
13. Burdo J.R., Simpson I.A., Menzies S., Beard J., Connor J.R. Regulation of the profile of iron-management proteins in brain microvasculature. J Cereb Blood Flow Metab 2004, 24:67-74.
14. Burn J., Chinnery P.F. Neuroferritinopathy. Semin Pediatr Neurol 2006, 13:176-181.
15. Burri B.J., Sweetman L., Nyhan W.L. Heterogeneity of holocarboxylase synthetase in patients with biotin-responsive multiple carboxylase deficiency. Am J Hum Genet 1985, 37:326-337.
16. Chang Y.Z., Qian Z.M., Wang K., Zhu L., Yang X.D., Du J.R., Jiang L., Ho K.P., Wang Q., Ke Y. Effects of development and iron status on ceruloplasmin expression in rat brain. J Cell Physiol 2005, 204:623-631.
17. Clardy S.L., Wang X., Zhao W., Liu W., Chase G.A., Beard J.L., True Felt B., Connor J.R. Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain. J Neural Transm Suppl 2006, 71:173-196.
18. Cooper J.D. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. Curr Opin Neurol 2003, 16:121-128.
19. Crosby A.H., Proukakis C. Is the transportation highway the right road for hereditary spastic paraplegia?. Am J Hum Genet 2002, 71:1009-1016.
20. Cuesta A., Pedrola L., Sevilla T., Garcia-Planells J., Chumillas M.J., Mayordomo F., LeGuern E., Marin I., Vilchez J.J., Palau F. The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 2002, 30:22-25.
21. Deane R., Zheng W., Zlokovic B.V. Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain. J Neurochem 2004, 88:813-820.
22. Dong X.P., Cheng X., Mills E., Delling M., Wang F., Kurz T., Xu H. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 2008, 455:992-996.
23. Dornelles A.S., Garcia V.A., de Lima M.N., Vedana G., Alcalde L.A., Bogo M.R., Schroder N. mRNA expression of proteins involved in iron homeostasis in brain regions is altered by age and by iron overloading in the neonatal period. Neurochem Res 2010, 35:564-571.
24. Drake S.F., Morgan E.H., Herbison C.E., Delima R., Graham R.M., Chua A.C., Leedman P.J., Fleming R.E., Bacon B.R., Olynyk J.K., Trinder D. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Am J Physiol Gastrointest Liver Physiol 2007, 292:G323-G328.
25. Dupic F., Fruchon S., Bensaid M., Loreal O., Brissot P., Borot N., Roth M.P., Coppin H. Duodenal mRNA expression of iron related genes in response to iron loading and iron deficiency in four strains of mice. Gut 2002, 51:648-653.
26. Fagan S.C., Hess D.C., Hohnadel E.J., Pollock D.M., Ergul A. Targets for vascular protection after acute ischemic stroke. Stroke 2004, 35:2220-2225.
27. Ferrari G., Lamantea E., Donati A., Filosto M., Briem E., Carrara F., Parini R., Simonati A., Santer R., Zeviani M. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain 2005, 128:723-731.
28. Fleming R.E., Migas M.C., Holden C.C., Waheed A., Britton R.S., Tomatsu S., Bacon B.R., Sly W.S. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci USA 2000, 97:2214-2219.
29. Frei K.P., Patronas N.J., Crutchfield K.E., Altarescu G., Schiffmann R. Mucolipidosis type IV: characteristic MRI findings. Neurology 1998, 51:565-569.
30. Galy B., Holter S.M., Klopstock T., Ferring D., Becker L., Kaden S., Wurst W., Grone H.J., Hentze M.W. Iron homeostasis in the brain: complete iron regulatory protein 2 deficiency without symptomatic neurodegeneration in the mouse. Nat Genet 2006, 38:967-969.
31. Golub M.S., Germann S.L., Araiza R.S., Reader J.R., Griffey S.M., Lloyd K.C. Movement disorders in the Hfe knockout mouse. Nutr Neurosci 2005, 8:239-244.
32. Gregory A., Polster B.J., Hayflick S.J. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet 2009, 46:73-80.
33. Hall C.N., Keynes R.G., Garthwaite J. Cytochrome P450 oxidoreductase participates in nitric oxide consumption by rat brain. Biochem J 2009, 419:411-418.
34. Hovell C.J., Collett J.A., Vautier G., Cheng A.J., Sutanto E., Mallon D.F., Olynyk J.K., Cullen D.J. High prevalence of coeliac disease in a population-based study from Western Australia: a case for screening?. Med J Aust 2001, 175:247-250.
35. Hyman C.B., Landing B., Alfin-Slater R., Kozak L., Weitzman J., Ortega J.A. Dl-alpha-tocopherol, iron, and lipofuscin in thalassemia. Ann N Y Acad Sci 1974, 232:211-220.
36. Johansson E., Lindh U., Westermarck T., Heiskala H., Santavuori P. Altered elemental profiles in neuronal ceroid lipofuscinosis. J Trace Elem Electrolytes Health Dis 1990, 4:139-142.
37. Kakhlon O., Gruenbaum Y., Cabantchik Z.I. Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells. Blood 2001, 97:2863-2871.
38. Kaldor I. Studies on intermediary iron metabolism. V. The measurement of non-haemoglobin tissue iron. Aust J Exp Biol Med Sci 1954, 32:795-799.
39. Ke Y., Chang Y.Z., Duan X.L., Du J.R., Zhu L., Wang K., Yang X.D., Ho K.P., Qian Z.M. Age-dependent and iron-independent expression of two mRNA isoforms of divalent metal transporter 1 in rat brain. Neurobiol Aging 2005, 26:739-748.
40. Kidane T.Z., Sauble E., Linder M.C. Release of iron from ferritin requires lysosomal activity. Am J Physiol Cell Physiol 2006, 291:C445-C455.
41. Kim S., Ponka P. Role of nitric oxide in cellular iron metabolism. Biometals 2003, 16:125-135.
42. LaVaute T., Smith S., Cooperman S., Iwai K., Land W., Meyron-Holtz E., Drake S.K., Miller G., Abu-Asab M., Tsokos M., Switzer R., Grinberg A., Love P., Tresser N., Rouault T.A. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 2001, 27:209-214.
43. Li W., Rusiniak M.E., Chintala S., Gautam R., Novak E.K., Swank R.T. Murine Hermansky-Pudlak syndrome genes: regulators of lysosome-related organelles. Bioessays 2004, 26:616-628.
44. Luscher T.F., Tanner F.C. Endothelial regulation of vascular tone and growth. Am J Hypertens 1993, 6:283S-293S.
45. Lykkesfeldt J., Morgan E., Christen S., Skovgaard L.T., Moos T. Oxidative stress and damage in liver, but not in brain, of Fischer 344 rats subjected to dietary iron supplementation with lipid-soluble [(3,5,5-trimethylhexanoyl)ferrocene]. J Biochem Mol Toxicol 2007, 21:145-155.
46. Macdonald R.A., Mallory G.K. Hemochromatosis and hemosiderosis. Study of 211 autopsied cases. Arch Intern Med 1960, 105:686-700.
47. Madsen E., Gitlin J.D. Copper and iron disorders of the brain. Annu Rev Neurosci 2007, 30:317-337.
48. McMonagle P., Byrne P.C., Fitzgerald B., Webb S., Parfrey N.A., Hutchinson M. Phenotype of AD-HSP due to mutations in the SPAST gene: comparison with AD-HSP without mutations. Neurology 2000, 55:1794-1800.
49. Meyron-Holtz E.G., Ghosh M.C., Iwai K., LaVaute T., Brazzolotto X., Berger U.V., Land W., Ollivierre-Wilson H., Grinberg A., Love P., Rouault T.A. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 2004, 23:386-395.
50. Miyasaki K., Murao S., Koizumi N. Hemochromatosis associated with brain lesions--a disorder of trace-metal binding proteins and/or polymers?. J Neuropathol Exp Neurol 1977, 36:964-976.
51. Moos T., Morgan E.H. Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol 2000, 20:77-95.
52. Moos T., Morgan E.H. A morphological study of the developmentally regulated transport of iron into the brain. Dev Neurosci 2002, 24:99-105.
53. Moos T., Oates P.S., Morgan E.H. Iron-independent neuronal expression of transferrin receptor mRNA in the rat. Brain Res Mol Brain Res 1999, 72:231-234.
54. Moos T., Oates P.S., Morgan E.H. Expression of transferrin mRNA in rat oligodendrocytes is iron-independent and changes with increasing age. Nutr Neurosci 2001, 4:15-23.
55. Moos T., Rosengren Nielsen T., Skjorringe T., Morgan E.H. Iron trafficking inside the brain. J Neurochem 2007, 103:1730-1740.
56. Moos T., Trinder D., Morgan E.H. Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain. Cell Mol Biol (Noisy-le-grand) 2000, 46:549-561.
57. Mori K., Lee H.T., Rapoport D., Drexler I.R., Foster K., Yang J., Schmidt-Ott K.M., Chen X., Li J.Y., Weiss S., Mishra J., Cheema F.H., Markowitz G., Suganami T., Sawai K., Mukoyama M., Kunis C., D'Agati V., Devarajan P., Barasch J. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005, 115:610-621.
58. Nelis E., Erdem S., Van Den Bergh P.Y., Belpaire-Dethiou M.C., Ceuterick C., Van Gerwen V., Cuesta A., Pedrola L., Palau F., Gabreels-Festen A.A., Verellen C., Tan E., Demirci M., Van Broeckhoven C., De Jonghe P., Topaloglu H., Timmerman V. Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Neurology 2002, 59:1865-1872.
59. Nikitovic D., Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem 1996, 271:19180-19185.
60. Okumura A.J., Hatsuzawa K., Tamura T., Nagaya H., Saeki K., Okumura F., Nagao K., Nishikawa M., Yoshimura A., Wada I. Involvement of a novel Q-SNARE, D12, in quality control of the endomembrane system. J Biol Chem 2006, 281:4495-4506.
61. Olynyk J.K., Cullen D.J., Aquilia S., Rossi E., Summerville L., Powell L.W. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999, 341:718-724.
62. Pacheco-Alvarez D., Solorzano-Vargas R.S., Gonzalez-Noriega A., Michalak C., Zempleni J., Leon-Del-Rio A. Biotin availability regulates expression of the sodium-dependent multivitamin transporter and the rate of biotin uptake in HepG2 cells. Mol Genet Metab 2005, 85:301-307.
63. Perry T.L., Norman M.G., Yong V.W., Whiting S., Crichton J.U., Hansen S., Kish S.J. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol 1985, 18:482-489.
64. Pinero D.J., Li N.Q., Connor J.R., Beard J.L. Variations in dietary iron alter brain iron metabolism in developing rats. J Nutr 2000, 130:254-263.
65. Ponka P. Rare causes of hereditary iron overload. Semin Hematol 2002, 39:249-262.
66. Qian Z.M., Chang Y.Z., Zhu L., Yang L., Du J.R., Ho K.P., Wang Q., Li L.Z., Wang C.Y., Ge X., Jing N.L., Li L., Ke Y. Development and iron-dependent expression of hephaestin in different brain regions of rats. J Cell Biochem 2007, 102:1225-1233.
67. Rosin B., Nevet A., Elias S., Rivlin-Etzion M., Israel Z., Bergman H. Physiology and pathophysiology of the basal ganglia-thalamo-cortical networks. Parkinsonism Relat Disord 2007, 13(Suppl 3):S437-439.
68. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
69. Rouault T.A., Cooperman S. Brain iron metabolism. Semin Pediatr Neurol 2006, 13:142-148.
70. Sardon T., Baltrons M.A., Garcia A. Nitric oxide-dependent and independent down-regulation of NO-sensitive guanylyl cyclase in neural cells. Toxicol Lett 2004, 149:75-83.
71. Sastry S., Arendash G.W. Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex. Neuroscience 1995, 67:649-666.
72. Schmidt H.H., Walter U. NO at work. Cell 1994, 78:919-925.
73. Schulz P.E., Weiner S.P., Belmont J.W., Fishman M.A. Basal ganglia calcifications in a case of biotinidase deficiency. Neurology 1988, 38:1326-1328.
74. Siintola E., Topcu M., Aula N., Lohi H., Minassian B.A., Paterson A.D., Liu X.Q., Wilson C., Lahtinen U., Anttonen A.K., Lehesjoki A.E. The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter. Am J Hum Genet 2007, 81:136-146.
75. Sobotka T.J., Whittaker P., Sobotka J.M., Brodie R.E., Quander D.Y., Robl M., Bryant M., Barton C.N. Neurobehavioral dysfunctions associated with dietary iron overload. Physiol Behav 1996, 59:213-219.
76. Spinazzola A., Viscomi C., Fernandez-Vizarra E., Carrara F., D'Adamo P., Calvo S., Marsano R.M., Donnini C., Weiher H., Strisciuglio P., Parini R., Sarzi E., Chan A., DiMauro S., Rotig A., Gasparini P., Ferrero I., Mootha V.K., Tiranti V., Zeviani M. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006, 38:570-575.
77. Street V.A., Bennett C.L., Goldy J.D., Shirk A.J., Kleopa K.A., Tempel B.L., Lipe H.P., Scherer S.S., Bird T.D., Chance P.F. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003, 60:22-26.
78. Suzuki Y., Aoki Y., Ishida Y., Chiba Y., Iwamatsu A., Kishino T., Niikawa N., Matsubara Y., Narisawa K. Isolation and characterization of mutations in the human holocarboxylase synthetase cDNA. Nat Genet 1994, 8:122-128.
79. Swaiman K.F. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991, 48:1285-1293.
80. Sweetman L. Two forms of biotin-responsive multiple carboxylase deficiency. J Inherit Metab Dis 1981, 4:53-54.
81. Tepper J.M., Lee C.R. GABAergic control of substantia nigra dopaminergic neurons. Prog Brain Res 2007, 160:189-208.
82. Terman A., Brunk U.T. Lipofuscin. Int J Biochem Cell Biol 2004, 36:1400-1404.
83. Terman A., Gustafsson B., Brunk U.T. Autophagy, organelles and ageing. J Pathol 2007, 211:134-143.
84. Zhang H., Fan X., Bagshaw R.D., Zhang L., Mahuran D.J., Callahan J.W. Lysosomal membranes from beige mice contain higher than normal levels of endoplasmic reticulum proteins. J Proteome Res 2007, 6:240-249.
85. Zhao M., Antunes F., Eaton J.W., Brunk U.T. Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. Eur J Biochem 2003, 270:3778-3786.